Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
The Journal of Craniofacial Surgery|May 26, 2005
Radiation-induced mandibular osteogenic sarcoma: report of a case and review of the literatureVicente Valentí, Antonio López-Pousa, Yolanda Gonzalez, et al.Cancer Investigation|December 17, 2021
Fooled by Randomness. The Misleading Effect of Treatment Crossover in Randomized Trials of Therapies with Marginal Treatment BenefitVicente Valentí, Paula Jiménez-Fonseca, Pavlos Msaouel, et al.Medicina Clinica|August 29, 2018
Aproach to the risk of delirium in an orthogeriatric unitEugenia Sopena Bert, Rami Qanneta, Vicente Valentí Moreno, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 17, 2025
Bayesian selection of lipidome dynamics features for a K-nearest neighbors (KNN) classifier model of tumor response in patients with advanced gastrointestinal adenocarcinoma undergoing systemic treatmentVicente Valentí, Javier Ramos, Laura Fernández-Sénder, et al.Neuroendocrinology|May 10, 2022
Streptozotocin, 1982-2022: Forty Years from the FDA's Approval to Treat Pancreatic Neuroendocrine TumorsJaume Capdevila, Michel Ducreux, Rocio García Carbonero, et al.Cancer Investigation|November 17, 2023
Variation of Plasma Damage-Associated Molecular Patterns in Patients with Advanced Solid Tumors after Standard of Care Systemic TreatmentVicente Valentí, Laia Capdevila, Isabel Ruiz, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 16, 2011
Phase I/II docetaxel plus concurrent hyperfractionated radiotherapy in locally advanced unresectable head and neck cancer (TAX.ES1.102 study)Agustí Barnadas, Ricard Mesía, Margarita Majem, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 2, 2006
Prevention of irinotecan associated diarrhea by intestinal alkalization. A pilot study in gastrointestinal cancer patientsVicente Valentí Moreno, Joan Brunet Vidal, Hermini Manzano Alemany, et al.European Journal of Cancer (Oxford, England : 1990)|June 6, 2006
A phase I clinical and pharmacokinetic study of paclitaxel and docetaxel given in combination in patients with solid tumoursMiguel Angel Izquierdo, Margarita García, José Luis Pontón, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2005
Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancerRicardo Hitt, Antonio López-Pousa, Javier Martínez-Trufero, et al.Pageof 1